CONDITIONS FOR IMMUNOSUPPRESSION BY RIFAMPICIN

被引:40
作者
BASSI, L
DIBERNAR.L
ARIOLI, V
SILVESTRI, LG
LIGNIERE, EL
机构
[1] UNIV PAVIA, CLIN MED, PAVIA, ITALY
[2] GRUPPO LEPETIT SPA, 20158 MILAN, ITALY
关键词
D O I
10.1093/infdis/128.6.736
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:736 / 744
页数:9
相关论文
共 27 条
  • [1] ARRIGONI-MARTELLI E, 1971, Pharmacological Research Communications, V3, P239, DOI 10.1016/0031-6989(71)90019-1
  • [2] BENEZRA D, 1972, ISRAEL J MED SCI, V8, P987
  • [3] BLINKOFF RC, 1966, J IMMUNOL, V97, P736
  • [4] BRAUN W, 1972, IMMUNOGENICITY
  • [5] DAJANI BM, 1972, LANCET, V2, P1094
  • [6] Davis B.D., 1968, MICROBIOLOGY
  • [7] FREIDLIN I S, 1972, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V49, P66
  • [8] FURESZ S, 1970, ANTIBIOT CHEMOTHER, V16, P316
  • [9] GIALDRONIGRASSI G, 1972, J INFECT DIS, V126, P542
  • [10] SPECIFIC INHIBITION OF DNA-DIRECTED RNA SYNTHESIS BY RIFAMYCIN
    HARTMANN, G
    HONIKEL, KO
    KNUSEL, F
    NUESCH, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1967, 145 (03) : 843 - &